Last reviewed · How we verify
human autologous synovial stem cells
Human autologous synovial stem cells are used to repair or replace damaged tissues in the body.
Human autologous synovial stem cells are used to repair or replace damaged tissues in the body. Used for Osteoarthritis, Rheumatoid arthritis.
At a glance
| Generic name | human autologous synovial stem cells |
|---|---|
| Sponsor | FUJIFILM Toyama Chemical Co., Ltd. |
| Modality | Biologic |
| Therapeutic area | Orthopedics |
| Phase | Phase 3 |
Mechanism of action
This involves the injection of autologous stem cells into the affected area, where they can differentiate into various cell types and promote tissue repair. The exact mechanism of action is not fully understood, but it is thought to involve the release of growth factors and other signaling molecules that stimulate tissue regeneration.
Approved indications
- Osteoarthritis
- Rheumatoid arthritis
Common side effects
- Pain at injection site
- Swelling at injection site
- Infection
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: